Supernus PharmaceuticalsSUPN
那斯達克 · USD
42.00
-0.92
(-2.14%)
收盤 09/19 03:59 (UTC+8)
09/19 03:59 (UTC+8)
Supernus PharmaceuticalsSUPN
42.00
-0.92
(-2.14%)
財務數據
損益表
- 1.44
- 1.68
- 1.76
- 1.74
- 1.50
- 1.65
- 1.92
- 2.12
- 2.08
- 2.19
- -12.58
- 17.18
- 4.37
- -0.87
- -13.97
- 10.43
- 16.11
- 10.13
- -1.83
- 5.47
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 219,058 | 207,705 | 211,572 | 192,103 | 165,453 | 149,824 | 174,159 | 175,689 | 168,325 | 143,644 |
營業成本 | 33,669 | 23,391 | 23,007 | 18,965 | 16,827 | 15,763 | 26,098 | 17,583 | 17,916 | 16,309 |
營業毛利 | 185,389 | 184,314 | 188,565 | 173,138 | 148,626 | 134,061 | 148,061 | 158,106 | 150,409 | 127,335 |
營業費用 | 243,352 | 192,646 | 192,502 | 233,369 | 136,485 | 144,317 | 126,656 | 117,261 | - | - |
研發費用 | 29,463 | 39,438 | 27,827 | 29,366 | 22,115 | 26,927 | 28,647 | 29,036 | 26,183 | 24,930 |
推銷及管理費用 | 133,637 | 127,564 | 140,149 | 179,678 | 93,551 | 97,604 | 79,765 | 68,737 | 81,549 | 85,421 |
非經常性項目費用 | 54,919 | - | - | - | - | - | - | - | - | - |
其他營業費用 | 25,333 | 25,644 | 24,526 | 24,325 | 20,819 | 19,786 | 18,244 | 19,488 | 20,108 | 20,137 |
營業利益 | -3,044 | -8,332 | -3,937 | -60,231 | 12,141 | -10,256 | 21,405 | 40,845 | 22,569 | -3,153 |
其他收入及費用 | 2,630 | 2,382 | 2,023 | 2,277 | 4,528 | 4,425 | 4,977 | 4,098 | 3,733 | 3,396 |
利息費用 | 2,315 | - | - | - | - | - | - | - | - | - |
稅前純益 | -57,648 | -5,950 | -1,914 | -57,954 | 16,669 | -5,831 | 26,382 | 44,943 | 26,302 | 243 |
所得稅 | 723 | -3,657 | 2,191 | -12,837 | -5,830 | 5,996 | 11,054 | 6,446 | 6,386 | 119 |
稅後純益 | -58,371 | -2,293 | -4,105 | -45,117 | 22,499 | -11,827 | 15,328 | 38,497 | 19,916 | 124 |
基本每股稅後盈餘(元) | -1.01 | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 | 0.28 | 0.70 | 0.36 | - |
稀釋每股稅後盈餘(元) | -1.01 | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 | 0.27 | 0.69 | 0.36 | - |
基本平均股數(千股) | 58070.00 | 57647.00 | 57344.00 | 56552.00 | 56024.00 | 55864.00 | 55465.00 | 55149.00 | 54978.00 | 54801.00 |
稀釋平均股數(千股) | 58070.00 | 57647.00 | 57344.00 | 56552.00 | 56643.00 | 55864.00 | 56464.00 | 56016.00 | 55724.00 | 55626.00 |
還原基本每股稅後盈餘(元) | -1.01 | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 | 0.28 | 0.70 | 0.36 | - |
還原稀釋每股稅後盈餘(元) | -1.01 | -0.04 | -0.07 | -0.80 | 0.40 | -0.21 | 0.27 | 0.69 | 0.36 | - |
還原基本平均股數(千股) | 58,070 | 57,647 | 57,344 | 56,552 | 56,024 | 55,864 | 55,465 | 55,149 | 54,978 | 54,801 |
還原稀釋平均股數(千股) | 58,070 | 57,647 | 57,344 | 56,552 | 56,643 | 55,864 | 56,464 | 56,016 | 55,724 | 55,626 |
EBITDA(千元) | -29,926 | 19,990 | 23,600 | -34,069 | 37,995 | 13,478 | 44,553 | 66,011 | 46,657 | 22,886 |